Ashland price target lowered to $77 from $84 at BMO Capital

BMO Capital lowered the firm’s price target on Ashland (ASH) to $77 from $84 and keeps a Market Perform rating on the shares. The company continues to see uncertainty around its core Life Sciences segment while the timing of its overall organic recovery also remains unclear, the analyst tells investors in a research note. Ashland will remain in the penalty box until the business shows a fundamental recovery in earnings, the firm added.